Skip to content.

Companies

Acquired by Apple

Acquired by Apple

Acquired by Capital D

Acquired by Capital D

Acquired by Oracle

Acquired by Oracle

Acquired by Siemens

Acquired by Siemens

Acquired by ERT Clinical

Acquired by ERT Clinical

LON: AREC

LON: AREC

NASDAQ: ORTX

NASDAQ: FRLN

NASDAQ: ACHL

NASDAQ: MGTX

Acquired by Facebook

NASAQ: BKNG

Explore our investments

  • UCL Tech Fund investments
  • Established
    2016
    In collaboration with UCL Business
  • Total investment
    > $2bn
    Over $2bn of follow on funding for portfolio
  • Public offerings
    4 IPOs
    Four NASDAQ IPOs since 2018

Featured investments

Web

Bramble Energy among 23 deeptech startups primed to take off | Business Insider

Bramble Energy | Business Insider

Read the article >
Events

UCL Technology Fund Showcase 2022

British Museum, London

Read the article >
News
Oversubscribed Series B round

Epsilogen secures £30.75m in an oversubscribed Series B financing round

Read the article >
Companies
  • Achilles Therapeutics
    https://achillestx.com/
    Biopharmaceutical company developing precision T cell therapies
    Sector: UCL Tech Fund
    Status: Nasdaq IPO
  • Axovia Therapeutics
    https://axoviatherapeutics.com/
    Gene therapy company developing disease-transformative medicines for ciliopathies
    Sector: UCL Tech Fund
    Status: Early Stage
  • Bloomsbury AI
    Enabling everyone to easily create their own question-answering system
    Sector: UCL Tech Fund
    Status: Exited
  • Bramble Energy
    https://www.brambleenergy.com/
    Fuel cell company on a mission to help the world achieve net zero
    Sector: UCL Tech Fund
    Status: Growth
  • Carbon Re
    https://www.carbonre.tech/
    Climate tech startup utilising AI to achieve operational efficiency in energy intensive industries
    Sector: UCL Tech Fund
    Status: Early Stage
  • Echopoint Medical
    https://www.echopointmedical.com/
    Transforming interventional cardiology with optical-fibre based sensors
    Sector: UCL Tech Fund
    Status: Early Stage
  • Epsilogen
    https://epsilogen.com/
    Immuno-oncology company targeting cancer with the IgE class of antibodies
    Sector: UCL Tech Fund
    Status: Early Stage
  • Freeline Therapeutics
    https://www.freeline.life/
    Biopharmaceutical company focused on the development of liver-directed gene therapies
    Sector: UCL Tech Fund
    Status: Nasdaq IPO
  • Hazy
    https://hazy.com/
    Synthetic data platform
    Sector: UCL Tech Fund
    Status: Early Stage
  • Humanloop
    https://humanloop.com/
    DevOps tool that rapidly builds NLP models that continuously improve
    Sector: UCL Tech Fund
    Status: Early Stage
  • Intrinsic
    https://www.intrinsicsemi.com/
    Developing a new type of all silicon non-volatile memory
    Sector: UCL Tech Fund
    Status: Early Stage
  • Meira GTX
    https://meiragtx.com/
    Vertically integrated, clinical stage gene therapy company
    Sector: UCL Tech Fund
    Status: Nasdaq IPO
  • NovalGen
    https://www.novalgen.com/
    Immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer
    Sector: UCL Tech Fund
    Status: Early Stage
  • Nozzle.ai
    https://www.nozzle.ai/
    AI powered platform that unifies large datasets and automatically optimises sales performance for marketplace sellers
    Sector: UCL Tech Fund
    Status: Early Stage
  • Odin Vision
    https://odin-vision.com/
    Builds a new era of cloud connected endoscopy
    Sector: UCL Tech Fund
    Status: Early Stage
  • Orchard Therapeutics
    https://www.orchard-tx.com/
    Biotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
    Sector: UCL Tech Fund
    Status: Nasdaq IPO
  • Panangium Therapeutics
    Biologic for retinal disease targeting a novel alternative pathway to VEGF
    Sector: UCL Tech Fund
    Status: Early Stage
  • Phasecraft
    https://phasecraft.io/
    Using disruptive theory to unlock the power of quantum computing
    Sector: UCL Tech Fund
    Status: Early Stage
  • Quell Therapeutics
    https://quell-tx.com/
    Cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions
    Sector: UCL Tech Fund
    Status: Growth
  • Third Space Learning
    https://thirdspacelearning.com/
    EdTech platform connecting tutors in the developing countries to students in developed economies
    Sector: UCL Tech Fund
    Status: Early Stage

Let’s talk